ECMO-Therapie bei COVID-19-ARDS in der Schwangerschaft ermöglicht den Erhalt einer Schwangerschaft mit termingerechter Entbindung

Sitter, Magdalena; Fröhlich, Corinna; Kranke, Peter; Markus, Christian; Wöckel, Achim; Rehn, M.; Bartmann, Catharina; Frieauff, Eric; Meybohm, Patrick; Pecks, Ulrich; Röder, Daniel

doi:10.1007/s00101-022-01232-6

Cited by 3 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the presented case, the decision that was determined was to place VV ECMO after assessing the state of refractory hypoxemia and the lack of response to the rest of the treatments. Published case reports of pregnant women with severe COVID-19 disease who were supported with VV ECMO describe satisfactory outcomes [ 4 , 12 , 24 , 25 , 26 ].…”

Section: Discussionmentioning

confidence: 99%

Severe COVID-19 Infection during Pregnancy Requiring ECMO: Case Report and Review of the Literature

Diago-Muñoz

Martínez-Varea

Pérez-Sancho

et al. 2023

JPM

View full text Add to dashboard Cite

The risk of developing severe COVID-19 that requires admission to an intensive care unit (ICU) and invasive ventilation is increased in pregnant women. Extracorporeal membrane oxygenation (ECMO) has been successfully used to manage critical pregnant and peripartum patients. Case Report: A 40-year-old patient, unvaccinated for COVID-19, presented to a tertiary hospital in January 2021 at 23 weeks of gestation due to respiratory distress, cough, and fever. The patient had a confirmed diagnosis of SARS-CoV-2 with a PCR test in a private center 48 hours before. She required admission into the ICU due to respiratory failure. High-flow nasal oxygen therapy, intermittent noninvasive mechanical ventilation (BiPAP), mechanical ventilation, prone positioning, and nitric oxide therapy were administered. Additionally, hypoxemic respiratory failure was diagnosed. Thus, circulatory assistance using ECMO with venovenous access was performed. After 33 days of ICU admission, the patient was transferred to the internal medicine department. She was discharged 45 days after hospital admission. At 37 weeks of gestation, the patient presented active labor and underwent an uneventful vaginal delivery. Conclusions: Severe COVID-19 in pregnancy may lead to the requirement for ECMO administration. This therapy should be administered in specialized hospitals using a multidisciplinary approach. COVID-19 vaccination should be strongly recommended to pregnant women to decrease the risk of severe COVID-19.

show abstract